KRISTINA BASILE: Open Payments
NPI 1790297810 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,092 in 65 payments from 20 companies in 2025. Trend: 2023 $0 · 2024 $504 · 2025 $1,092
Food & beverage: $980Education: $111
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $238 |
| Teva Pharmaceuticals USA, Inc. | 6 | $185 |
| PFIZER INC. | 12 | $157 |
| Axsome Therapeutics, Inc. | 1 | $88 |
| Novartis Pharmaceuticals Corporation | 5 | $86 |
| Neurelis, Inc. | 3 | $51 |
| Amgen Inc. | 3 | $47 |
| UCB, Inc. | 2 | $36 |
| ARGENX US, INC. | 2 | $36 |
| Lundbeck LLC | 1 | $18 |
Products named: QULIPTA, NURTEC ODT, UBRELVY, Symbravo, KESIMPTA, AUSTEDO XR, VALTOCO, REPATHA.
Industry payments across NY — which companies pay providers there.
